Federal Register Recent Federal Regulation Documents - Justia Regulation Tracker - Justia Regulations Trackerhttps://regulations.justia.com/regulations/fedreg/agencies/department-of-health-and-human-services/2024/10/18?limit=200®isters=between&mode=atom2025-01-10T04:26:09-08:00Justia Inchttps://www.justia.com/Justia Regulations Trackerhttps://regulations.justia.com/images/justiafedregulations.gifCopyright 2011 Justia Inchttps://regulations.justia.com/regulations/fedreg/2024/10/18/2024-24125.htmlNotice - Office of the Director; Notice of Meeting2024-10-18T00:00:00-07:002024-10-18T00:00:00-07:002024-24125Noticehttps://www.govinfo.gov/content/pkg/FR-2024-10-18/pdf/2024-24125.pdfhttps://regulations.justia.com/regulations/fedreg/2024/10/18/2024-24111.htmlNotice - Core Patient-Reported Outcomes in Cancer Clinical Trials; Guidance for Industry; Availability2024-10-18T00:00:00-07:002024-10-18T00:00:00-07:002024-24111Noticehttps://www.govinfo.gov/content/pkg/FR-2024-10-18/pdf/2024-24111.pdfhttps://regulations.justia.com/regulations/fedreg/2024/10/18/2024-24109.htmlNotice - Determination of Regulatory Review Period for Purposes of Patent Extension; EXXUA2024-10-18T00:00:00-07:002024-10-18T00:00:00-07:002024-24109Noticehttps://www.govinfo.gov/content/pkg/FR-2024-10-18/pdf/2024-24109.pdfhttps://regulations.justia.com/regulations/fedreg/2024/10/18/2024-24108.htmlNotice - Considerations for Long-Term Clinical Neurodevelopmental Safety Studies in Neonatal Product Development; Guidance for Industry; Availability2024-10-18T00:00:00-07:002024-10-18T00:00:00-07:002024-24108Noticehttps://www.govinfo.gov/content/pkg/FR-2024-10-18/pdf/2024-24108.pdfhttps://regulations.justia.com/regulations/fedreg/2024/10/18/2024-24107.htmlNotice - Postoperative Nausea and Vomiting: Developing Drugs for Prevention; Draft Guidance for Industry; Availability2024-10-18T00:00:00-07:002024-10-18T00:00:00-07:002024-24107Noticehttps://www.govinfo.gov/content/pkg/FR-2024-10-18/pdf/2024-24107.pdfhttps://regulations.justia.com/regulations/fedreg/2024/10/18/2024-24106.htmlNotice - Linde, Inc.; Withdrawal of Approval of a New Drug Application and New Animal Drug Application for Helium, USP2024-10-18T00:00:00-07:002024-10-18T00:00:00-07:002024-24106Noticehttps://www.govinfo.gov/content/pkg/FR-2024-10-18/pdf/2024-24106.pdfhttps://regulations.justia.com/regulations/fedreg/2024/10/18/2024-24104.htmlNotice - Review of Drug Master Files in Advance of Certain Abbreviated New Drug Application Submissions Under Generic Drug User Fee Amendments; Guidance for Industry; Availability2024-10-18T00:00:00-07:002024-10-18T00:00:00-07:002024-24104Noticehttps://www.govinfo.gov/content/pkg/FR-2024-10-18/pdf/2024-24104.pdfhttps://regulations.justia.com/regulations/fedreg/2024/10/18/2024-24103.htmlNotice - Determination That TAVIST (Clemastine Fumarate) Tablet, 2.68 Milligrams, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness2024-10-18T00:00:00-07:002024-10-18T00:00:00-07:002024-24103Noticehttps://www.govinfo.gov/content/pkg/FR-2024-10-18/pdf/2024-24103.pdfhttps://regulations.justia.com/regulations/fedreg/2024/10/18/2024-24165.htmlNotice - Meeting of the National Advisory Council on Migrant Health; Amended Notice of Meeting2024-10-18T00:00:00-07:002024-10-18T00:00:00-07:002024-24165Noticehttps://www.govinfo.gov/content/pkg/FR-2024-10-18/pdf/2024-24165.pdfhttps://regulations.justia.com/regulations/fedreg/2024/10/18/2024-24133.htmlNotice - Charter Renewal of the Advisory Committee on Blood and Tissue Safety and Availability2024-10-18T00:00:00-07:002024-10-18T00:00:00-07:002024-24133Noticehttps://www.govinfo.gov/content/pkg/FR-2024-10-18/pdf/2024-24133.pdfhttps://regulations.justia.com/regulations/fedreg/2024/10/18/2024-24147.htmlNotice - Meeting of the Secretary's Advisory Committee on Human Research Protections2024-10-18T00:00:00-07:002024-10-18T00:00:00-07:002024-24147Noticehttps://www.govinfo.gov/content/pkg/FR-2024-10-18/pdf/2024-24147.pdfhttps://regulations.justia.com/regulations/fedreg/2024/10/18/2024-24100.htmlRule - Regulatory Hearing Before the Food and Drug Administration; General Provisions; Amendments; Correction2024-10-18T00:00:00-07:002024-10-18T00:00:00-07:002024-24100Rulehttps://www.govinfo.gov/content/pkg/FR-2024-10-18/pdf/2024-24100.pdfhttps://regulations.justia.com/regulations/fedreg/2024/10/18/2024-24098.htmlNotice - Recommendations for the Development of Blood Collection, Processing, and Storage Systems for the Manufacture of Blood Components Using the Buffy Coat Method; Draft Guidance for Industry; Availability2024-10-18T00:00:00-07:002024-10-18T00:00:00-07:002024-24098Noticehttps://www.govinfo.gov/content/pkg/FR-2024-10-18/pdf/2024-24098.pdfhttps://regulations.justia.com/regulations/fedreg/2024/10/18/2024-24096.htmlNotice - The Accreditation Scheme for Conformity Assessment Program: Draft Guidances for Industry, Accreditation Bodies, Testing Laboratories, and FDA Staff; Availability; Extension of Comment Period2024-10-18T00:00:00-07:002024-10-18T00:00:00-07:002024-24096Noticehttps://www.govinfo.gov/content/pkg/FR-2024-10-18/pdf/2024-24096.pdfhttps://regulations.justia.com/regulations/fedreg/2024/10/18/2024-24095.htmlNotice - Determination of Regulatory Review Period for Purposes of Patent Extension; Wavewriter Alpha Spinal Cord Stimulator System2024-10-18T00:00:00-07:002024-10-18T00:00:00-07:002024-24095Noticehttps://www.govinfo.gov/content/pkg/FR-2024-10-18/pdf/2024-24095.pdfhttps://regulations.justia.com/regulations/fedreg/2024/10/18/2024-24058.htmlNotice - National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting2024-10-18T00:00:00-07:002024-10-18T00:00:00-07:002024-24058Noticehttps://www.govinfo.gov/content/pkg/FR-2024-10-18/pdf/2024-24058.pdfhttps://regulations.justia.com/regulations/fedreg/2024/10/18/2024-24057.htmlNotice - National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting2024-10-18T00:00:00-07:002024-10-18T00:00:00-07:002024-24057Noticehttps://www.govinfo.gov/content/pkg/FR-2024-10-18/pdf/2024-24057.pdf